<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01554787</url>
  </required_header>
  <id_info>
    <org_study_id>DMR100-IRB-251</org_study_id>
    <nct_id>NCT01554787</nct_id>
  </id_info>
  <brief_title>Randomized, Double Blind, Placebo Control Trial to Evaluate the Efficacy of Astragalus Membranaceus in the Patients After Stroke With Fatigue</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>China Medical University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>China Medical University Hospital</source>
  <brief_summary>
    <textblock>
      The high levels of fatigue in stroke patients without neurological impairment suggest it has
      a central origin rather than being the result of increased physical effort required after
      stroke（Winward et al., 2009）. Fatigue is different from post-stroke depression and the more
      serious stroke patients are more prone to fatigue（Windward et al., 2009）.

      Fatigue is one of the symptoms of qi deficiency,and Astragalus membranaceus is the most
      effective of all traditional Chinese medicine and can tonifying middle and tonify the
      original qi. Therefore, the aim of this study was to investigate the efficacy of Astragalus
      membranaceus on post-stroke fatigue.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>January 2012</start_date>
  <primary_completion_date type="Anticipated">December 2013</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>EORTC QLQ-C30</measure>
    <time_frame>2 year(all patients)</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>BFI-T score</measure>
    <time_frame>2 years(all patients)</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>SF-36 score</measure>
    <time_frame>2 years(all patients)</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">90</enrollment>
  <condition>Fatigue</condition>
  <condition>Stroke</condition>
  <arm_group>
    <arm_group_label>Chinese Herb Astragalus membranaceus</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Chinese Herb Astragalus membranaceus</intervention_name>
    <description>Astragalus membranaceus(AM)at a rate of 2.8g three times per day</description>
    <arm_group_label>Chinese Herb Astragalus membranaceus</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>at a rate of 2.8g three times per day</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Gender: Male or female.

          2. Age: between 40 and 80 years old.

          3. Three months after stroke.

          4. Hemorrhagic stroke or ischemic stroke.

          5. Fatigue score from screen process ≧4.

          6. Subject with comprehension or communication.

          7. Volunteer signs the agreement to participate the study after whole study purpose and
             procedures description in detail.

        Exclusion Criteria:

          1. People from mental illness can not to participate the evaluation.

          2. Major diseases such as cancer、Chronic pulmonary obstructive disease(COPD)、 Heart
             failure、Myocardial Infraction、Chronic renal failure or Liver cirrhosis.

          3. Pregnant woman.

          4. Breast-feeding woman.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Chung Hsiang Liu, MD.</last_name>
    <role>Principal Investigator</role>
    <affiliation>China Medical University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Chung Hsiang Liu, MD.</last_name>
    <phone>886-4-22052121</phone>
    <phone_ext>7635</phone_ext>
    <email>greengen@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>China Medical University Hospital</name>
      <address>
        <city>Taichung</city>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Chung Hsiang Liu, MD.</last_name>
    </contact>
    <investigator>
      <last_name>Chung Hsiang Liu, MD.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <verification_date>March 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 7, 2012</study_first_submitted>
  <study_first_submitted_qc>March 13, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 15, 2012</study_first_posted>
  <last_update_submitted>March 13, 2012</last_update_submitted>
  <last_update_submitted_qc>March 13, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 15, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>After stroke with fatigue</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
    <mesh_term>Fatigue</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

